See what's coming. + + + = + + + = - CareAllies

4 downloads 212 Views 70KB Size Report
See what's coming. The Medicare Access and CHIP Reauthorization Act ... Streamlines PQRS, VM and MU programs to work as
MACRA MINUTE See what’s coming. The Medicare Access and CHIP Reauthorization Act (MACRA) was designed to tie more payments to value, while simplifying reporting for physicians. MACRA timing 2016

2017

2018

Final ruling due by end of 2016

First performance year is 2017

2019 Impacts payments in 2019

(full year rather than 90 days)

MERIT-BASED INCENTIVE PAYMENT SYSTEM

MIPS

Most physicians will begin payment through this modified fee-for-service model. Streamlines PQRS, VM and MU programs to work as one, more flexible program. New component promotes and rewards practice improvement and innovation.

Two tracks for physician payment

ELIGIBLE ADVANCED ALTERNATIVE PAYMENT MODEL Annual bonus payment is available for physicians participating in payment models specifically approved by the Centers for Medicare & Medicaid Services (CMS).

APM

There are currently multiple individual

Physician Quality Reporting Program (PQRS)

quality and value programs for Medicare physicians and practitioners.

Medicare EHR Incentive Program

Value-based payment modifier

MACRA streamlines these programs into MIPS

Merit-based Incentive Payment System (MIPS) “The Medicare Access & Chip Reauthorization Act of 2015: Path to Value” Centers for Medicare & Medicaid Services

MIPS Composite Performance Score categories

Quality

50%

+

Advanced Care Information

+

25%

Clinical Practice Improvement Activities

Resource Use

+

MSSP Track 1 ACO

Payment adjustments

providers in MIPS qualify for preferential scoring, which could positively affect reimbursement.

=

10%

15%

Physicians and groups with Composite Performance Scores that fall above a threshold will receive bonuses. Those that fall below the threshold will face penalties.

Composite Performance Score (CPS)

Scores are public

Consumers will be able to view and compare scores on the CMS website.

“The Medicare Access & Chip Reauthorization Act of 2015: Path to Value” Centers for Medicare & Medicaid Services

Advanced APMS Payments based on MIPS-like quality measures

+

Quality measures:

Certified EHRT

+

CEHRT:

Minimum payment or patient threshold

+

Nominal risk:

50% of participants must use in 2017, 75% in 2018

Must be comparable to MIPS (e.g., have an outcome measure)

More than nominal risk

4% of expected expenditures; Marginal risk of 30%; Minimum loss ratio capped at 4%

Advanced APM and 5% bonus

=

Payments:

25% of all Medicare payments: Increases to 75% by 2024

Payment thresholds:

20% of all Medicare patients: Increases to 50% by 2024

“The Medicare Access & Chip Reauthorization Act of 2015: Path to Value” Centers for Medicare & Medicaid Services

What are my options? Am I an APM?

Am I an Advanced APM?

YES

NO

Do I have enough payments or patients through my Advanced APM? YES

Is this my first year in Medicare OR am I below the low-volume threshold?

YES

YES

NO

FAVORABLE MIPS SCORING AND ADVANCED APM SPECIFIC REWARDS

Not subject to MIPS

NO

Subject to MIPS

NO

Qualified Advanced APM Participant (QP) • Excluded from MIPS • 5% lump-sum bonus payment (2019–2024) • APM Specific rewards

Bottom line: There will be financial incentives for participating in an Advanced APM, even if you don’t become a QP.

“The Medicare Access & Chip Reauthorization Act of 2015: Path to Value” Centers for Medicare & Medicaid Services

CareAllies can help you maximize your reimbursements. We partner with you to assess your readiness and provide performance projections, conduct market opportunity assessments and can even support you with a comprehensive MACRA program strategy and operating model based on your organization’s needs. Just ask.

CareAllies.com

866.302.7560

[email protected]

All CareAllies products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including CareAllies, Inc. The CareAllies name, logo, and other CareAllies marks are owned by Cigna Intellectual Property, Inc. 900022 09/16

© 2016 CareAllies, Inc.